careers investors newsroom suppliers login worldwide ELI LILLY AND COMPANY home about responsibility products r & d R & D A DETERMINATION TO DISCOVER APPROACH TO R&D CLINICAL STUDIES CLINICAL DEVELOPMENT PIPELINE OPEN INNOVATION INNOVATION STARTS HERE ADVANCE INNOVATION WITH LILLY R&D LOCATIONS Latest News from LRL Lilly's Commitment to Global Innovation Reinforced with Opening of New Diabetes-Focused Research and Development Center in Shanghai NIH and Lilly to generate public resource of approved and investigational medicines For 140 years, we have worked tirelessly to discover medicines that make life better. From the development of insulin to the manufacturing of the polio vaccine to the discovery of medicines that treat mental illness, we have been pioneers behind breakthroughs against some of humanity’s most stubborn and devastating diseases. We bring this same determination to our work today, uniting our expertise with the creativity of research partners across the globe to keep finding ways to make life better. This determination starts in the Lilly Research Laboratories (LRL) where more than 9,000 Lilly employees in more than 55 countries work to discover new medicines that will help solve our world’s greatest health challenges. "Research is the Heart of the Business, the Soul of the Enterprise." Mr. Eli Lilly GRANDSON OF THE COMPANY FOUNDER, COLONEL ELI LILLY CLINICAL TRIALS REGISTRY CLINICAL DEVELOPMENT PIPELINE Copyright © 2015 Eli Lilly and Company. All rights reserved. terms of use privacy sitemap contact